Quality of life in patients with benign thyroid disorders. A review

European Journal of Endocrinology

Volumn 154, Issue 4, 2006, Pages 501-510

  Watt, Torquil ^a,b   Groenvold, Mogens ^b   Rasmussen, Åse Krogh ^a   Bonnema, Steen Joop ^c   Hegedüs, Laszlo ^c   Bjorner, Jakob Bue ^d   Feldt Rasmussen, Ulla ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d QualityMetric Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE;

CINAHL; CONTENT VALIDITY; ENDOCRINE OPHTHALMOPATHY; GOITER; HORMONAL THERAPY; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MEDLINE; PRIORITY JOURNAL; PSYCINFO; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; REVIEW; SYSTEMATIC REVIEW; THYROID DISEASE; THYROID SURGERY; TREATMENT OUTCOME; TREATMENT RESPONSE; VALIDATION PROCESS;

GRAVES OPHTHALMOPATHY; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MEDLINE; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; THYROID DISEASES;

EID: 33646035188     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02124     Document Type: Review

References (106)

1. Guyatt GH, Feeny DH & Patrick DL. Measuring health-related quality of life. Annals of Internal Medicine 1993 118 622-629.
2. Hays RD. Generic versus disease-targeted instruments. In Assessing Quality of Life in Clinical Trials, pp 3-8. Eds P Fayers & RD Hays. Oxford: Oxford University Press, 2005.
3. Ladenson PW. Psychological well-being in patients. Clinical Endocrinology 2002 57 575-576.
4. Abraham P, Avenell A, Watson WA, Park CM, Bevan JS. Antithyroid Drug Regimen for Treating Graves' Hyperthyroidism (Cochrane Review), The Cochrane Library, issue 3. Chichester, UK: John Wiley & Sons, Ltd., 2004.
5. Romijn JA, Smit JW & Lamberts SW. Intrinsic imperfections of endocrine replacement therapy. European Journal of Endocrinology 2003 149 91-97.
6. Bennedbaek FN, Perrild H & Hegedüs L. Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey. Clinical Endocrinology 1999 50 357-363.
7. Bennedbaek FN & Hegedüs L. Management of the solitary thyroid nodule: results of a North American survey. Journal of Clinical Endocrinology and Metabolism 2000 85 2493-2498.
8. Bhagat MC, Dhaliwal SS, Bonnema SJ, Hegedüs L & Walsh JP. Differences between endocrine surgeons and endocrinologists in the management of non-toxic multinodular goitre. British Journal of Surgery 2003 90 1103-1112.
9. Bonnema SJ, Bennedbaek FN, Wiersinga WM & Hegedüs L. Management of the nontoxic multinodular goitre: a European questionnaire study. Clinical Endocrinology 2000 53 5-12.
10. Bonnema SJ, Bennedbaek FN, Ladenson PW & Hegedüs L. Management of the nontoxic multinodular goiter: a North American survey. Journal of Clinical Endocrinology and Metabolism 2002 87 112-117.
11. Escobar-Jimenez F, Fernandez-Soto ML, Luna-Lopez V, Quesada-Charneco M & Glinoer D. Trends in diagnostic and therapeutic criteria in Graves' disease in the last 10 years. Postgraduate Medical Journal 2000 76 340-344.
12. Geelhoed-Duyvestijn PH, Haak A, Hermans J & van der Heide D. Treatment of hypothyroidism in The Netherlands. Results of a survey of Dutch internists. Netherlands Journal of Medicine 1989 34 72-80.
13. Haak A, Geelhoed-Duyvestijn PH, Hermans J & van der Heide D. Diagnosis and treatment of Graves' disease. Results of a survey of Dutch internists. Netherlands Journal of Medicine 1989 34 64-71.
14. Solomon B, Glinoer D, Lagasse R & Wartofsky L. Current trends in the management of Graves' disease. Journal of Clinical Endocrinology and Metabolism 1990 70 1518-1524.
15. Wartofsky L, Glinoer D, Solomon B, Nagataki S, Lagasse R, Nagayama Y & Izumi M. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. Thyroid 1991 1 129-135.
16. Bianchi GP, Zaccheroni V, Solaroli E, Vescini F, Cerutti R, Zoli M & Marchesini G. Health-related quality of life in patients with thyroid disorders. Quality of Life Research 2004 13 45-54.
17. Elberling TV, Rasmussen AK, Feldt-Rasmussen U, Hording M, Perrild H & Waldemar G. Impaired health-related quality of life in Graves' disease. A prospective study. European Journal of Endocrinology 2004 151 549-555.
18. Razvi S, Ingoe LE, McMillan CV & Weaver JU. Health status in patients with sub-clinical hypothyroidism. European Journal of Endocrinology 2005 152 713-717.
19. Fayers PM & Machin D. Quality of Life: Assessment, Analysis and Interpretation. Chichester: John Wiley and Sons, 2000.
20. Streiner DL & Norman GR. Health Measurement Scales. A Practical Guide to their Development and Use, 2nd edn., Oxford: Oxford University Press, 1995.
21. Sprangers MA, Cull A, Bjordal K, Groenvold M & Aaronson NK. The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life. Quality of Life Research 1993 2 287-295.
22. Testa MA & Simonson DC. Assessment of quality-of-life out-comes. New England Journal of Medicine 1996 334 835-840.
23. Assessing Quality of Life in Clinical Trials - Methods and Practice, 2nd edn., Eds, PM Fayers & RD Hays. Oxford: Oxford University Press, 2004.
24. Fahrenfort JJ, Wilterdink AM & van der Veen EA. Long-term residual complaints and psychosocial sequelae after remission of hyperthyroidism. Psychoneuroendocrinology 2000 25 201-211.
25. Terwee CB, Gerding MN, Dekker FW, Prummel MF & Wiersinga WM. Development of a disease-specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL. British Journal of Ophthalmology 1998 82 773-779.
26. Tehrani M, Krummenauer F, Mann WJ, Pitz S, Dick HB & Kahaly GJ. Disease-specific assessment of quality of life after decompression surgery for Graves' ophthalmopathy. European Journal of Ophthalmology 2004 14 193-199.
27. Jaeschke R, Guyatt G, Cook D, Harper S & Gerstein HC. Spectrum of quality of life impairment in hypothyroidism. Quality of Life Research 1994 3 323-327.
28. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R & Dayan CM. Psychological well-being in patients on 'adequate' doses of L-thyroxine: results of a large, controlled community-based questionnaire study. Clinical Endocrinology 2002 57 577-585.
29. McMillan CV, Bradley C, Woodcock A, Razvi S & Weaver JU. Design of new questionnaires to measure quality of life and treatment satisfaction in hypothyroidism. Thyroid 2004 14 916-925.
30. Wayne EJ. The diagnosis of thyrotoxicosis. British Medical Journal 1954 4859 411-419.
31. Crooks J, Murray IP & Wayne EJ. Statistical methods applied to the clinical diagnosis of thyrotoxicosis. Quarterly Journal of Medicine 1959 28 211-234.
32. Murray IP. The clinical diagnosis of thyroid disease. Medical Journal of Australia 1964 13 827-831.
33. Gurney C, Hall R, Harper M, Owen SG, Roth M & Smart GA. Newcastle thyrotoxicosis index. Lancet 1970 2 1275-1278.
34. Benvenga S, Ruggeri RM, Russo A, Lapa D, Campenni A & Trimarchi F. Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial. Journal of Clinical Endocrinology and Metabolism 2001 86 3579-3594.
35. Klein I, Trzepacz PT, Roberts M & Levey GS. Symptom rating scale for assessing hyperthyroidism. Archives of Internal Medicine 1988 148 387-390.
36. Wayne E. The assessment of thyroid function. British Journal of Surgery 1965 52 717-721.
37. Billewicz WZ, Chapman RS, Crooks J, Day ME, Gossage J, Wayne E & Young JA. Statistical methods applied to the diagnosis of hypothyroidism. Quarterly Journal of Medicine 1969 38 255-266.
38. Zulewski H, Muller B, Exer P, Miscrez AR & Staub JJ. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. Journal of Clinical Endocrinology and Metabolism 1997 82 771-776.
39. Barker DJ & Bishop JM. Computer-based screening system for patients at risk of hypothyroidism. Lancet 1969 2 835-838.
40. Gardner MJ & Barker DJ. Diagnosis of hypothyroidism: a comparison of statistical techniques. British Medical Journal 1975 2 260-262.
41. Cooper DS, Halpern R, Wood LC, Levin AA & Ridgway EC. L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Annals of Internal Medicine 1984 101 18-24.
42. Canaris GJ, Steiner JF & Ridgway EC. Do traditional symptoms of hypothyroidism correlate with biochemical disease? Journal of General Internal Medicine 1997 12 544-550.
43. Canaris GJ, Manowitz NR, Mayor G & Ridgway EC. The Colorado thyroid disease prevalence study. Archives of Internal Medicine 2000 160 526-534.
44. Terwee CB, Gerding MN, Dekker FW, Prummel MF, van der Pol JP & Wiersinga WM. Test-retest reliability of the GO-QOL: a disease-specific quality of life questionnaire for patients with Graves' ophthalmopathy. Journal of Clinical Epidemiology 1999 52 875-884.
45. Terwee CB, Dekker FW, Mourits MP, Gerding MN, Baldeschi L, Kalmann R, Prummel MF & Wiersinga WM. Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments. Clinical Endocrinology 2001 54 391-398.
46. Wiersinga WM, Prummel MF & Terwee CB. Effects of Graves' ophthalmopathy on quality of life. Journal of Endocrinological Investigation 2004 27 259-264.
47. Jaeschke R, Guyatt G, Gerstein H, Patterson C, Molloy W, Cook D, Harper S, Griffith L & Carbotte R. Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? Journal of General Internal Medicine 1996 11 744-749.
48. Biondi B, Palmieri EA, Fazio S, Cosco C, Nocera M, Sacca L, Filetti S, Lombardi G & Perticone F. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. Journal of Clinical Endocrinology and Metabolism 2000 85 4701-4705.
49. Gerding MN, Terwee CB, Dekker FW, Koornneef L, Prummel MF & Wiersinga WM. Quality of life in patients with Graves' ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid 1997 7 885-889.
50. Terwee C, Wakelkamp I, Tan S, Dekker F, Prummel MF & Wiersinga W. Long-term effects of Graves' ophthalmopathy on health-related quality of life. European Journal of Endocrinology 2002 146 751-757.
51. Egle UT, Kahaly GJ, Petrak F, Hardt J, Batke J, Best J & Rothenbacher M. The relevance of physical and psychosocial factors for the quality of life in patients with thyroid-associated orbitopathy (TAO). Experimental and Clinical Endocrinology and Diabetes 1999 107 (Suppl 5) S168-S171.
52. Harrison LC, Buckley JD & Martin FI. Use of a computer-based postal questionnaire for the detection of hypothyroidism following radioiodine therapy for thyrotoxicosis. Australian and New Zealand Journal of Medicine 1977 7 27-32.
53. Escobar-Morreale HF, Botella-Carretero JI, Gomez-Bueno M, Galan JM, Barrios V & Sancho J. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Annals of Internal Medicine 2005 142 412-424.
54. Zeitlhofer J, Saletu B, Stary J & Ahmadi R. Cerebral function in hyperthyroid patients. Psychopathology, psychometric variables, central arousal and time perception before and after thyreostatic therapy. Neuropsychobiology 1984 11 89-93.
55. Demet MM, Ozmen B, Deveci A, Boyvada S, Adiguzel H & Aydemir O. Depression and anxiety in hyperthyroidism. Archives of Medical Research 2002 33 552-556.
56. Rockey PH & Griep RJ. Behavioral dysfunction in hyperthyroidism. Improvement with treatment. Archives of Internal Medicine 1980 140 1194-1197.
57. Stern RA, Robinson B, Thorner AR, Arruda JE, Prohaska ML & Prange AJ Jr. A survey study of neuropsychiatric complaints in patients with Graves' disease. Journal of Neuropsychiatry and Clinical Neurosciences 1996 8 181-185.
58. Park JJ, Sullivan TJ, Mortimer RH, Wagenaar M & Perry-Keene DA. Assessing quality of life in Australian patients with Graves' ophthalmopathy. British Journal of Ophthalmology 2004 88 75-78.
59. Braverman LE & Utiger RD, Eds. Werner and Ingbars The Thyroid - a Fundamental and Clinical Text, 7th edn., New York: Lippincott-Raven, 1996.
60. Ljunggren JG, Torring O, Wallin G, Taube A, Tallstedt L, Hamberger B & Lundell G. Quality of life aspects and costs in treatment of Graves' hyperthyroidism with antithyroid drugs, surgery, or radioiodine: results from a prospective, randomized study. Thyroid 1998 8 653-659.
61. Kathol RG, Turner R & Delahunt J. Depression and anxiety associated with hyperthyroidism: response to antithyroid therapy. Psychosomatics 1986 27 501-505.
62. O'Malley B, Hickey J & Nevens E. Thyroid dysfunction - weight problems and the psyche: the patients' perspective. Journal of Human Nutrition and Dietetics 2000 13 243-248.
63. Maugeri D, Motta M, Salerno G, Rosso D, Mazzarella R, Salomone S, Russo MS, Elia G & Panebianco P. Cognitive and affective disorders in hyper- and hypothyreotic elderly patients. Archives of Gerontology and Geriatrics 1998 Suppl. 6 305-312.
64. Trzepacz PT, McCue M, Klein I, Levey GS & Greenhouse J. A psychiatric and neuropsychological study of patients with untreated Graves' disease. General Hospital Psychiatry 1988 10 49-55.
65. Whybrow PC, Prange AJ Jr & Treadway CR. Mental changes accompanying thyroid gland dysfunction. A reappraisal using objective psychological measurement. Archives of General Psychiatry 1969 20 48-63.
66. Radanovic-Grguric L, Filakovic P, Barkic J, Mandic N, Karner I & Smoje J. Depression in patients with thyroid dysfunction. European Journal of Psychiatry 2003 17 133-144.
67. Lee IT, Sheu WH, Liau YJ, Lin SY, Lee WJ & Lin CC. Relationship of stressful life events, anxiety and depression to hyperthyroidism in an Asian population. Hormone Research 2003 60 247-251.
68. Paschke R, Harsch I, Schlote B, Vardarli I, Schaaf L, Kaumeier S, Teuber J & Usadel KH. Sequential psychological testing during the course of autoimmune hyperthyroidism. Klinische Wochenschrift 1990 68 942-950.
69. Farid M, Roch-Levecq AC, Levi L, Brody BL, Granet DB & Kikkawa DO. Psychological disturbance in Graves' ophthalmopathy. Archives of Ophthalmology 2005 123 491-496.
70. DeGroot LJ & Jameson JL, Eds. Endocrinology, 4th edn., Philadelphia: WB Saunders, 2001.
71. Wass JAH, Shalet SM, Gale E & Amiel SA, Eds. Oxford Textbook of Endocrinology and Diabetes, 1st edn., Oxford: Oxford University Press, 2002.
72. Kahaly GJ, Hardt J, Petrak F & Egle UT. Psychosocial factors in subjects with thyroid-associated ophthalmopathy. Thyroid 2002 12 237-239.
73. Laurberg P. Hypothyroidism. In The Thyroid Gland, pp 497-535. Ed. MA Greer. New York: Raven Press, 1990.
74. Jain VK. Affective disturbance in hypothyroidism. British Journal of Psychiatry 1971 119 279-280.
75. Gunnarsson T, Sjoberg S, Eriksson M & Nordin C. Depressive symptoms in hypothyroid disorder with some observations on biochemical correlates. Neuropsychobiology 2001 43 70-74.
76. Cleare AJ, McGregor A & O'Keane V. Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression. Clinical Endocrinology 1995 43 713-719.
77. Zettinig G, Asenbaum S, Fueger BJ, Hofmann A, Diemling M, Mittlboeck M & Dudczak R. Increased prevalence of subclinical brain perfusion abnormalities in patients with autoimmune thyroiditis: evidence of Hashimoto's encephalitis? Clinical Endocrinology 2003 59 637-643.
78. Trivalle C, Doucet J, Chassagne P, Landrin I, Kadri N, Menard JF & Bercoff E. Differences in the signs and symptoms of hyperthyroidism in older and younger patients. Journal of the American Geriatrics Society 1996 44 50-53.
79. Orgiazzi JJ & Mornex R. Hyperthyroidism. In The Thyroid Gland, pp 405-495. Ed. MA Greer. New York: Raven Press, 1990.
80. Wilson WP, Johnson JE & Smith RB. Affective change in thyrotoxicosis and experimental hypermetabolism. Recent Advances in Biological Psychiatry 1961 4 234-243.
81. Wallace JE, MacCrimmon DJ & Goldberg WM. Acute hyperthyroidism: cognitive and emotional correlates. Journal of Abnormal Psychology 1980 89 519-527.
82. Nordyke RA, Gilbert FI Jr & Harada AS. Graves' disease. Influence of age on clinical findings. Archives of Internal Medicine 1988 148 626-631.
83. Tak PP, Hermans J & Haak A. Symptomatology of Graves' disease and Plummer's disease in relation to age and thyroid hormone level. Netherlands Journal of Medicine 1993 42 157-162.
84. Yonem O, Dokmetas HS, Aslan SM & Erselcan T. Is antithyroid treatment really relevant for young patients with subclinical hyperthyroidism? Endocrine Journal 2002 49 307-314.
85. Davis PJ & Davis FB. Hyperthyroidism in patients over the age of 60 years. Clinical features in 85 patients. Medicine 1974 53 161-181.
86. Watanakunakorn C, Hodges RE & Evans TC. Myxedema: a study of 400 cases. Archives of Internal Medicine 1965 116 183-190.
87. Sait Gonen M, Kisakol G, Savas Cilli A, Dikbas O, Gungor K, Inal A & Kaya A. Assessment of anxiety in subclinical thyroid disorders. Endocrine Journal 2004 51 311-315.
88. Oddie TH, Boyd CM, Fisher DA & Hales IB. Incidence of signs and symptoms in thyroid disease. Medical Journal of Australia 1972 2 981-986.
89. Harper MB. Vomiting, nausea, and abdominal pain: unrecognized symptoms of thyrotoxicosis. Journal of Family Practice 1989 29 382-386.
90. Alvarez MA, Gomez A, Alavez E & Navarro D. Attention disturbance in Graves' disease. Psychoneuroendocrinology 1983 8 451-454.
91. Monzani F, Del Guerra P, Caraccio N, Pruneti CA, Pucci E, Luisi M & Baschieri L. Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment. Clinical Investigator 1993 71 367-371.
92. Eden S, Sundbeck G, Lindstedt G, Lundberg PA, Jagenburg R, Landahl S & Svanborg A. Screening for thyroid disease in the elderly. Serum concentrations of thyrotropin and 3,5,3′-triiodothyronine in a representative population of 79-year-old women and men. Comprehensive Gerontology Section A, Clinical and Laboratory Sciences 1988 2 40-45.
93. 131I therapy in patients with non-toxic multinodular goiter. European Journal of Endocrinology 1995 132 86-87.
94. Le Moli R, Wesche MF, Tiel-Van Buul MM & Wiersinga WM. Determinants of long-term outcome of radioiodine therapy of sporadic non-toxic goitre. Clinical Endocrinology 1999 50 783-789.
95. Bonnema SJ, Nielsen VE & Hogedüs L. Long-term effects of radioiodine on thyroid function, size and patient satisfaction in non-toxic diffuse goitre. European Journal of Endocrinology 2004 150 439-445.
96. Schlote B, Nowotny B, Schaaf L, Kleinbohl D, Schmidt R, Teuber J, Paschke R, Vardarli I, Kaumeier S & Usadel KH. Subclinical hyperthyroidism: physical and mental state of patients. European Archives of Psychiatry and Clinical Neuroscience 1992 241 357-364.
97. 4 replacement therapy. Clinical Endocrinology 1999 51 237-242.
98. Armistead SH. Symptoms of non-toxic nodular goitre. Ulster Medical Journal 1976 45 178-180.
99. Papa A, Cammarota G, Tursi A, Certo M, Montalto M, Capelli G, de Rosa G, Cuoco L, Fedeli G & Gasbarrini G. Effects of propylthiouracil on intestinal transit time and symptoms in hyperthyroid patients. Hepatogastroenterology 1997 44 426-429.
100. Filteau SM, Sullivan KR, Anwar US, Anwar ZR & Tomkins AM. Iodine deficiency alone cannot account for goitre prevalence among pregnant women in Modhupur, Bangladesh. European Journal of Clinical Nutrition 1994 48 293-302.
101. Berg G, Michanck A, Holmberg E & Nystrom E. Clinical outcome of radioiodine treatment of hyperthyroidism: a follow-up study. Journal of Internal Medicine 1996 239 165-171.
102. Bommer M, Eversmann T, Pickardt R, Leonhardt A & Naber D. Psychopathological and neuropsychological symptoms in patients with subclinical and remitted hyperthyroidism. Klinische Wochenschrift 1990 68 552-558.
103. Thomsen AF, Kvist TK, Andersen PK & Kessing LV. Increased risk of affective disorder following hospitalisation with hyperthyroidism - a register-based study. European Journal of Endocrinology 2005 152 535-543.
104. Perrild H, Hansen JM, Arnung K, Olsen PZ & Danielsen U. Intellectual impairment after hyperthyroidism. Acta Endocrinologica 1986 112 185-191.
105. Janssen S, Berg G, Lindstedt G, Michanek A & Nystrom E. Overweight - a common problem among women treated for hyperthyroidism. Postgraduate Medical Journal 1993 69 107-111.
106. Birring SS, Morgan AJ, Prudon B, McKeever TM, Lewis SA, Falconer Smith JF, Robinson RJ, Britton JR & Pavord ID. Respiratory symptoms in patients with treated hypothyroidism and inflammatory bowel disease. Thorax 2003 58 533-536.